AI-Powered Trading Intelligence
FP Advisory uses advanced AI to scan thousands of micro-cap stocks, filter out the noise, and deliver high-conviction trade ideas directly to your app and inbox — before the market opens.
About FP Advisory
FP Advisory combines institutional-grade data feeds with a multi-stage AI pipeline to identify genuinely actionable swing trade opportunities in US micro-cap equities.
We don't surface earnings beats or analyst upgrades. We find the events that matter — fresh catalysts, material contracts, FDA milestones — and give you a clear trade plan before the market reacts.
How it works
Every morning our system pulls news from Finnhub, Yahoo Finance, Google News, and SEC EDGAR across thousands of US micro-cap stocks — with strict freshness filters. If the catalyst is older than 3 days, it's out.
A two-pass AI pipeline first rejects routine updates, earnings-beat-only stories, and analyst commentary. The survivors get a detailed rationale covering catalyst, technicals, risk, and expected timeline.
A separate AI model validates every idea against strict rules — freshness, materiality, price movement since the catalyst. Only ideas that pass all checks are published to the app and sent as notifications.
What you get
Every idea comes with a specific entry price, stop-loss, and profit target — plus the reward-to-risk ratio so you can size positions accordingly.
Each idea includes a detailed analyst-style breakdown covering the catalyst, why it matters relative to company size, technical context, and what could go wrong.
We reject private placements, LOIs, analyst upgrades, earnings beats without independent catalysts, and any news older than 72 hours. Only material, fresh, actionable events.
Every briefing opens with a market regime snapshot — VIX, S&P 500, oil — so you know immediately whether conditions favour the ideas or warrant extra caution.
Each idea includes a full 30-day OHLCV breakdown so you can see exactly how the stock moved before and after the catalyst — no need to pull up a chart separately.
View all ideas in the FP Advisory app the moment they're published. Get instant push notifications and email alerts so you never miss a setup — wherever you are.
How ideas reach you
Ideas are published to the FP Advisory app the moment they clear our validation pipeline. You choose how you want to be notified — we make sure you never miss a setup.
The primary home for all trade ideas. Browse current and historical setups, full rationales, and live market context in one clean interface.
Get an instant alert the moment a new idea is published. Tap through directly to the full rationale and trade levels.
A notification email sent as soon as new ideas are available, with a direct link into the app. No idea buried in your inbox — just a clean prompt to act.
Sample idea
Catalyst & News — Just 6 hours ago on 2026-06-15, RxStar announced FDA acceptance of their NDA filing for RS-441, a novel pain management compound. This is a binding regulatory milestone, not a routine update. The company has a market cap of roughly $180M — FDA acceptance at this size historically drives sustained re-rating as binary risk shifts materially. The stock closed at $2.91 the day prior; at $3.42 it has moved +17.5% since the news, well within range given the significance of the catalyst.
Technical context — The stock consolidated below $3.50 for three weeks before this. Volume today is running at 4.2x the 90-day average — institutional accumulation, not retail noise. Entry at current price of $3.42. Stop below recent consolidation lows at $2.80. Target of $5.10 represents the pre-weakness high from February and a logical first resistance.
Expected timeline — NDA acceptance coverage will continue building over the next 5-10 days. Primary move expected within 3-7 trading sessions.
Get access
Tell us a bit about yourself and we'll get you set up with access to the FP Advisory platform. Individuals, prop traders, and small funds all welcome.
hello@fpadvisory.com